Cargando…

Janus Kinase 2 Polymorphisms Are Associated with Risk in Patients with Gastric Cancer in a Chinese Population

AIM: To evaluate the impact of the Janus kinase 2 single nucleotide polymorphisms (SNPs) on gastric cancer risk. METHODS: In this hospital-based, case–control study, the genotypes were identified by polymerase chain reaction–restriction fragment length polymorphism protocols in 661 individuals (359...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Li, Liu, Dongxiao, Liang, Song, Guo, Renhua, Zhang, Zhihong, Xu, Hao, Yang, Chao, Zhu, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663844/ https://www.ncbi.nlm.nih.gov/pubmed/23717640 http://dx.doi.org/10.1371/journal.pone.0064628

Ejemplares similares

Risk-Association of DNA Methyltransferases Polymorphisms with Gastric Cancer in the Southern Chinese Population
por: Yang, Xue-Xi, et al.
Publicado: (2012)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Janus Kinases in Leukemia
por: Raivola, Juuli, et al.
Publicado: (2021)

Polymorphisms of VDR gene and risk of gastric cardiac adenocarcinoma in Chinese population
por: Yin, Jun, et al.
Publicado: (2017)

Impact of PSCA gene polymorphisms in modulating gastric cancer risk in the Chinese population
por: Yan, Kangpeng, et al.
Publicado: (2019)

PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese population
por: Qiu, Li-Xin, et al.
Publicado: (2016)

Itch and Janus Kinase Inhibitors
por: HAN, Yujin, et al.
Publicado: (2023)

No association between single nucleotide polymorphisms in pre-mirnas and the risk of gastric cancer in Chinese population
por: Pu, Jia-Yuan, et al.
Publicado: (2014)

Relationship between MEG3 gene polymorphism and risk of gastric cancer in Chinese population with high incidence of gastric cancer
por: Kong, Xiaoling, et al.
Publicado: (2020)

Polymorphisms in ERCC1 and XPF Genes and Risk of Gastric Cancer in an Eastern Chinese Population
por: He, Jing, et al.
Publicado: (2012)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
por: BALLANGER, Fabienne, et al.
Publicado: (2023)

Janus kinase inhibitors: jackpot or potluck?
por: Pavithran, Keechilat, et al.
Publicado: (2012)

Janus Kinase Inhibitors and Cell Therapy
por: Assal, Amer, et al.
Publicado: (2021)

Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer
por: Zhao, Fujun, et al.
Publicado: (2012)

Polymorphisms in lncRNA PTENP1 and the Risk of Gastric Cancer in a Chinese Population
por: Ge, Yugang, et al.
Publicado: (2017)

PLCE1 Polymorphisms and Risk of Esophageal and Gastric Cancer in a Northwestern Chinese Population
por: Liang, Ping, et al.
Publicado: (2019)

Association of Genetic Polymorphisms in the LncRNAs with Gastric Cancer Risk in a Chinese Population
por: He, Bang-Shun, et al.
Publicado: (2017)

Potential Use of Janus Kinase Inhibitors in the Treatment of Systemic Lupus Erythematosus
por: Huo, Rongxiu, et al.
Publicado: (2023)

Redox regulation of Janus kinase: The elephant in the room
por: Duhé, Roy J
Publicado: (2013)

The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
por: Veale, Douglas J, et al.
Publicado: (2019)

Clinical significance of Janus Kinase inhibitor selectivity
por: Choy, Ernest H
Publicado: (2019)

Clinical significance of Janus Kinase inhibitor selectivity
por: Choy, Ernest H
Publicado: (2019)

Janus kinase inhibitors for the therapy of atopic dermatitis
por: Traidl, Stephan, et al.
Publicado: (2021)

Role of Janus Kinase Inhibitors in Therapy of Psoriasis
por: Słuczanowska-Głąbowska, Sylwia, et al.
Publicado: (2021)

Janus kinase inhibitors in autoimmune bullous diseases
por: Huang, Dawei, et al.
Publicado: (2023)

Structural basis of Janus kinase trans-activation
por: Caveney, Nathanael A., et al.
Publicado: (2023)

Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review
por: Wen, Ji, et al.
Publicado: (2021)

Functional polymorphisms in NR3C1 are associated with gastric cancer risk in Chinese population
por: Gu, Yayun, et al.
Publicado: (2017)

A Functional Polymorphism (rs2494752) in the AKT1 Promoter Region and Gastric Adenocarcinoma Risk in an Eastern Chinese Population
por: Wang, Meng-Yun, et al.
Publicado: (2016)

Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk
por: Rajasimhan, Suraj, et al.
Publicado: (2020)

Clinical Manifestation of Calreticulin Gene Mutations in Essential Thrombocythemia without Janus Kinase 2 and MPL Mutations: A Chinese Cohort Clinical Study
por: Sun, Chao, et al.
Publicado: (2016)

Polymorphisms in the XPC gene and gastric cancer susceptibility in a Southern Chinese population
por: Hua, Rui-Xi, et al.
Publicado: (2016)

Genetic polymorphisms are associated with the risk of gastric and colorectal cancers in a Han Chinese population
por: Wang, Nan, et al.
Publicado: (2017)

Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors
por: Knight, Emily A., et al.
Publicado: (2015)

The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease
por: De Vries, L.C.S., et al.
Publicado: (2017)

Role of janus kinase inhibitors in the treatment of alopecia areata
por: Triyangkulsri, Korn, et al.
Publicado: (2018)

Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
por: Hammitzsch, Ariane, et al.
Publicado: (2020)

Targeting the Janus Kinase Family in Autoimmune Skin Diseases
por: Howell, Michael D., et al.
Publicado: (2019)

Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers
por: Li, Boheng, et al.
Publicado: (2021)

Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
por: Qi, Fei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hn2uhtpt2p4t40ju3rmiimbokp